作者对２２０例不能手术的肺癌患者，采用了支气管动脉内灌注大剂量抗癌药加综合解毒措施进行治疗，并与单纯采用常规量抗癌药支气管动脉内灌注治疗的患者作临床对照分析。结果显示，实验组ＣＲ＋ＰＲ率（８１．８％）明显高于对照组（５０．０％），经ｔ检验，Ｐ＜０．０５．且全身副作用较对照组轻。治疗后，病人症状得到缓解，生存期延长，或再选择手术切除肿瘤。 The authors treated 220 cases of lung cancer patients who could not be operated with bronchial arterial infusion of high-dose anticancer drugs plus comprehensive detoxification measures, and compared them with patients who were treated with a conventional amount of anticancer drug bronchial arterial infusion alone. The results showed that the experimental group CR+PR rate (81.8%) was significantly higher than the control group (50.0%), the t test, P <0.05. And the systemic side effects were lighter than the control group. After the treatment, the patient’s symptoms are relieved, the survival time is prolonged, or he or she is given a surgical resection.